Integra lifesciences holdings corp (IART)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08
Revenue from Contract with Customer, Excluding Assessed Tax

1,517,557

1,472,441

1,188,236

992,075

882,734

796,717

696,832

830,871

780,078

732,068

682,487

654,604

Costs and expenses:
Cost of goods sold

564,681

571,496

435,511

349,089

326,542

302,946

279,548

314,427

299,150

268,188

244,918

252,826

Research and development

79,573

78,041

63,455

58,155

50,895

43,559

42,622

51,012

51,451

48,114

44,280

60,495

In-process research and development

64,916

0

0

-

-

-

-

-

-

-

-

-

Selling, general and administrative

687,599

690,746

624,096

455,629

415,757

375,545

332,190

373,114

358,132

305,055

281,102

280,997

Intangible asset amortization

27,028

21,160

20,370

13,862

9,953

6,810

7,099

18,536

16,433

12,017

14,363

12,875

Goodwill impairment charge

-

-

-

-

-

-

-

0

0

-

-

-

Total costs and expenses

1,423,797

1,361,443

1,143,432

876,735

803,147

728,860

661,459

757,089

725,166

633,374

584,663

607,193

Operating income

93,760

110,998

44,804

115,340

79,587

67,857

35,373

73,782

54,912

98,694

97,824

47,411

Interest income

10,779

2,800

255

24

30

168

4,933

1,205

465

225

631

2,114

Interest expense

53,957

64,683

35,019

25,803

23,534

21,967

19,725

22,237

27,640

18,356

23,227

30,085

Other income(expense), net

9,522

8,288

1,345

845

4,588

-492

-1,795

-721

757

1,551

-2,076

-905

Income before income taxes

60,104

57,403

11,385

90,406

60,671

45,566

18,786

52,029

28,494

82,114

73,152

18,535

Provision (benefit) for income taxes

9,903

-3,398

-53,358

15,842

53,820

9,271

-3,241

10,825

505

16,445

22,197

-9,192

Net income from continuing operations

-

-

-

-

6,851

36,295

22,027

-

-

-

-

-

Loss from discontinued operations (net of tax benefit)

-

-

-

-

-10,370

-2,291

-43,094

-

-

-

-

-

Net income

50,201

60,801

64,743

74,564

-3,519

34,004

-21,067

41,204

27,989

65,669

50,955

27,727

Net income per share
Income from continuing operations (in dollars per share)

-

-

-

-

0.10

0.56

0.78

-

-

-

-

-

Loss from discontinued operations (in dollars per share)

-

-

-

-

-0.15

-0.04

-1.52

-

-

-

-

-

Basic (in dollars per share)

0.59

0.73

0.84

1.00

-0.05

0.52

-0.74

1.46

0.97

2.21

1.75

0.98

Income from continuing operations (in dollars per share)

-

-

-

-

0.10

0.55

0.76

-

-

-

-

-

Loss from discontinued operations (in dollars per share)

-

-

-

-

-0.15

-0.03

-1.50

-

-

-

-

-

Diluted (in dollars per share)

0.58

0.72

0.82

0.94

-0.05

0.52

-0.74

1.44

0.95

2.17

1.74

0.96

Weighted average common shares outstanding (See Note 13):
Basic (in shares)

85,637

82,857

76,897

74,386

68,990

64,864

28,416

28,232

28,952

29,548

29,038

27,781

Diluted (in shares)

86,494

83,999

79,121

79,194

71,354

65,920

28,802

28,516

29,495

30,149

29,292

28,378